Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Federica Edith Pisa

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Future Oncology (London, England)|March 10, 2018
MGMT pyrosequencing-based cut-off methylation level and clinical outcome in patients with glioblastoma multiformeLorena Gurrieri, Elisa De Carlo, Lorenzo Gerratana, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 15, 2014
Risk of unplanned visits for colorectal cancer outpatients receiving chemotherapy: a case-crossover studyLuisa Foltran, Giuseppe Aprile, Federica Edith Pisa, et al.
Journal of Inherited Metabolic Disease|September 15, 2010
Long-term observational, non-randomized study of enzyme replacement therapy in late-onset glycogenosis type IIBruno Bembi, Federica Edith Pisa, Marco Confalonieri, et al.
Anticancer Research|April 12, 2015
Bevacizumab and first-line chemotherapy for older patients with advanced colorectal cancer: final results of a Community-based Observational Italian StudyStefania Eufemia Lutrino, Francesca Bergamo, Marta Schirripa, et al.
Future Oncology (London, England)|February 17, 2015
Prognostic role of KRAS, NRAS, BRAF and PIK3CA mutations in advanced colorectal cancerLuisa Foltran, Giovanna De Maglio, Nicoletta Pella, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Future Oncology (London, England)|March 10, 2018
MGMT pyrosequencing-based cut-off methylation level and clinical outcome in patients with glioblastoma multiformeLorena Gurrieri, Elisa De Carlo, Lorenzo Gerratana, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 15, 2014
Risk of unplanned visits for colorectal cancer outpatients receiving chemotherapy: a case-crossover studyLuisa Foltran, Giuseppe Aprile, Federica Edith Pisa, et al.
Journal of Inherited Metabolic Disease|September 15, 2010
Long-term observational, non-randomized study of enzyme replacement therapy in late-onset glycogenosis type IIBruno Bembi, Federica Edith Pisa, Marco Confalonieri, et al.
Anticancer Research|April 12, 2015
Bevacizumab and first-line chemotherapy for older patients with advanced colorectal cancer: final results of a Community-based Observational Italian StudyStefania Eufemia Lutrino, Francesca Bergamo, Marta Schirripa, et al.
Future Oncology (London, England)|February 17, 2015
Prognostic role of KRAS, NRAS, BRAF and PIK3CA mutations in advanced colorectal cancerLuisa Foltran, Giovanna De Maglio, Nicoletta Pella, et al.
Pageof 3